Clinical Trial Update: A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma [Phase 1]

View source ↗

Summary

This document provides an update on a completed Phase 1 clinical trial evaluating mapatumumab in combination with sorafenib for advanced hepatocellular carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Mapatumumab (mapatumumab)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Human Genome Sciences Inc., a GSK Company | Conditions: Hepatocellular Carcinoma | Phase 1 | Status: COMPLETED